- Home
- RGNX vs CYRX Comparison
RGNX vs CYRX Comparison
Compare RGNX & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- CYRX
- Stock Information
- Founded
- RGNX 2008
- CYRX 1999
- Country
- RGNX United States
- CYRX United States
- Employees
- RGNX N/A
- CYRX N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- RGNX Health Care
- CYRX Health Care
- Exchange
- RGNX Nasdaq
- CYRX Nasdaq
- Market Cap
- RGNX 372.1M
- CYRX 422.6M
- IPO Year
- RGNX 2015
- CYRX N/A
- Fundamental
- Price
- RGNX $7.57
- CYRX $8.16
- Analyst Decision
- RGNX Strong Buy
- CYRX Buy
- Analyst Count
- RGNX 12
- CYRX 7
- Target Price
- RGNX $35.55
- CYRX $13.14
- AVG Volume (30 Days)
- RGNX 1.8M
- CYRX 261.6K
- Earning Date
- RGNX 02-25-2025
- CYRX 03-11-2025
- Dividend Yield
- RGNX N/A
- CYRX N/A
- EPS Growth
- RGNX N/A
- CYRX N/A
- EPS
- RGNX N/A
- CYRX N/A
- Revenue
- RGNX $84,327,000.00
- CYRX $226,113,000.00
- Revenue This Year
- RGNX $2.92
- CYRX N/A
- Revenue Next Year
- RGNX $256.82
- CYRX $7.70
- P/E Ratio
- RGNX N/A
- CYRX N/A
- Revenue Growth
- RGNX N/A
- CYRX N/A
- 52 Week Low
- RGNX $6.56
- CYRX $5.32
- 52 Week High
- RGNX $28.80
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- RGNX 45.51
- CYRX 53.74
- Support Level
- RGNX $6.98
- CYRX $6.97
- Resistance Level
- RGNX $7.70
- CYRX $8.97
- Average True Range (ATR)
- RGNX 0.54
- CYRX 0.55
- MACD
- RGNX 0.04
- CYRX -0.08
- Stochastic Oscillator
- RGNX 44.30
- CYRX 59.50
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.